Health Condition 1: N943- Premenstrual tension syndrome
Conditions
Interventions
Intervention1: Asarun: Asarun 3 gm daily orally in 2 divided doses from 15 day prior to the expected menstrual cycle
for 3 consequent cycles
Control Intervention1: Sumbul-ut-teeb: Sumbul-ut-teeb 4 gm
Sponsors
National Institute of Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged between 18 and 35 years. Having a regular menstrual cycle with a cycle length of 21-35 days. Presenting with symptoms of premenstrual syndrome (diagnosed by ACOG criteria). Having a minimum PMTS score more than 17 and VAS score more than 4.
Exclusion criteria
Exclusion criteria: Patients with any organic pelvic pathology,Use of hormonal therapy or oral contraceptives in past 3 months,A known systemic or metabolic disease (Thyroid disease, Diabetes mellitus, Hypertension).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in PMTS ScoreTimepoint: Follow up will be done monthly for 3 consecutive cycles during the trial and once after the completion of trial. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in VAS ScoreTimepoint: Follow up will be done monthly for 3 consecutive cycles during the trial and once after the completion of trial | — |
Countries
India
Contacts
Public ContactDr Kouser Fathima Firdous
National Institute of Unani Medicine
Outcome results
None listed